A phase II neoadjuvant trial of sequential triweekly nanoparticle albumin-bound paclitaxel and cyclophosphamide followed by 5-fluorouracil/epirubicin/ cyclophosphamide in the treatment of operable breast cancer.
Norio Masumoto
No relevant relationships to disclose
Takayuki Kadoya
No relevant relationships to disclose
Ai Amioka
No relevant relationships to disclose
Keiko Kajitani
No relevant relationships to disclose
Akiko Emi
No relevant relationships to disclose
Hideo Shigematsu
No relevant relationships to disclose
Rumi Haruta
No relevant relationships to disclose
Tsuyoshi Kataoka
No relevant relationships to disclose
Kazuo Matsuura
No relevant relationships to disclose
Morihito Okada
No relevant relationships to disclose